Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of N-methyl-d-aspartate agonists and antagonists

Yossef Itzhak

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Neurochemical studies have indicated that the dissociative anesthetics, phencyclidine (PCP) and ketamine, act as non-competitive antagonists at the excitatory amino acid, N-methyl-d-aspartate (NMDA), receptor-gated ion channel. Since the binding of PCP and related psychotomimetics, i.e. (+)-N-allylnormetazocine ((+)-SKF 10047), in mammalian brain is associated with multiple receptor subtypes, their modulation by NMDA agonists and antagonists was investigated. Binding of the potent PCP analog, [3H]PCP-3-OH to the high-affinity sigma/PCP (σp) site and (+)-[3H]SKF 10047 to the sigma/haloperidol sensitive (σh) site in rat brain membranes was not affected by l-glutamate and NMDA, nor by the competitive NMDA antagonists d-2-amino-5-phosphovaleric acid (AP-5), d-2-amino-7-phosphoheptanoic acid (AP-7). However, binding of [3H]PCP-3-OH to the low-affinity PCP-selective site was enhanced by 4- to 5-fold in the presence of glutamate or NMDA and reduced in a competitive manner by AP-5. The non-competitive NMDA antagonist, MK-801, was however a potent inhibitor of the binding to both σp and PCP sites labeled with [3H]PCP-3-OH. The present results indicate that the high (σp) and low-affinity (PCP) sites, that are distinct from the σh site, are affected differently by NMDA agonists and antagonists, and thus may represent different receptor domains.

Original languageEnglish
Pages (from-to)314-319
Number of pages6
JournalNeuroscience Letters
Volume104
Issue number3
DOIs
StatePublished - Oct 9 1989

Fingerprint

Phencyclidine Receptors
Aspartic Acid
2-amino-7-phosphonoheptanoic acid
Glutamic Acid
Dissociative Anesthetics
Phencyclidine
Excitatory Amino Acid Antagonists
Dizocilpine Maleate
Brain
Ketamine
Haloperidol
Ion Channels
Membranes

Keywords

  • (+)-N-Allylnormetazocine
  • Excitatory amino acid
  • N-Methyl-d-aspartate
  • Phencyclidine
  • Receptor regulation
  • Receptor subtype

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Different modulation of the binding to two phencyclidine (PCP) receptor subtypes : Effects of N-methyl-d-aspartate agonists and antagonists. / Itzhak, Yossef.

In: Neuroscience Letters, Vol. 104, No. 3, 09.10.1989, p. 314-319.

Research output: Contribution to journalArticle

@article{b1d26d1c8b7d4a91a471931ababdf221,
title = "Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of N-methyl-d-aspartate agonists and antagonists",
abstract = "Neurochemical studies have indicated that the dissociative anesthetics, phencyclidine (PCP) and ketamine, act as non-competitive antagonists at the excitatory amino acid, N-methyl-d-aspartate (NMDA), receptor-gated ion channel. Since the binding of PCP and related psychotomimetics, i.e. (+)-N-allylnormetazocine ((+)-SKF 10047), in mammalian brain is associated with multiple receptor subtypes, their modulation by NMDA agonists and antagonists was investigated. Binding of the potent PCP analog, [3H]PCP-3-OH to the high-affinity sigma/PCP (σp) site and (+)-[3H]SKF 10047 to the sigma/haloperidol sensitive (σh) site in rat brain membranes was not affected by l-glutamate and NMDA, nor by the competitive NMDA antagonists d-2-amino-5-phosphovaleric acid (AP-5), d-2-amino-7-phosphoheptanoic acid (AP-7). However, binding of [3H]PCP-3-OH to the low-affinity PCP-selective site was enhanced by 4- to 5-fold in the presence of glutamate or NMDA and reduced in a competitive manner by AP-5. The non-competitive NMDA antagonist, MK-801, was however a potent inhibitor of the binding to both σp and PCP sites labeled with [3H]PCP-3-OH. The present results indicate that the high (σp) and low-affinity (PCP) sites, that are distinct from the σh site, are affected differently by NMDA agonists and antagonists, and thus may represent different receptor domains.",
keywords = "(+)-N-Allylnormetazocine, Excitatory amino acid, N-Methyl-d-aspartate, Phencyclidine, Receptor regulation, Receptor subtype",
author = "Yossef Itzhak",
year = "1989",
month = "10",
day = "9",
doi = "10.1016/0304-3940(89)90595-8",
language = "English",
volume = "104",
pages = "314--319",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Different modulation of the binding to two phencyclidine (PCP) receptor subtypes

T2 - Effects of N-methyl-d-aspartate agonists and antagonists

AU - Itzhak, Yossef

PY - 1989/10/9

Y1 - 1989/10/9

N2 - Neurochemical studies have indicated that the dissociative anesthetics, phencyclidine (PCP) and ketamine, act as non-competitive antagonists at the excitatory amino acid, N-methyl-d-aspartate (NMDA), receptor-gated ion channel. Since the binding of PCP and related psychotomimetics, i.e. (+)-N-allylnormetazocine ((+)-SKF 10047), in mammalian brain is associated with multiple receptor subtypes, their modulation by NMDA agonists and antagonists was investigated. Binding of the potent PCP analog, [3H]PCP-3-OH to the high-affinity sigma/PCP (σp) site and (+)-[3H]SKF 10047 to the sigma/haloperidol sensitive (σh) site in rat brain membranes was not affected by l-glutamate and NMDA, nor by the competitive NMDA antagonists d-2-amino-5-phosphovaleric acid (AP-5), d-2-amino-7-phosphoheptanoic acid (AP-7). However, binding of [3H]PCP-3-OH to the low-affinity PCP-selective site was enhanced by 4- to 5-fold in the presence of glutamate or NMDA and reduced in a competitive manner by AP-5. The non-competitive NMDA antagonist, MK-801, was however a potent inhibitor of the binding to both σp and PCP sites labeled with [3H]PCP-3-OH. The present results indicate that the high (σp) and low-affinity (PCP) sites, that are distinct from the σh site, are affected differently by NMDA agonists and antagonists, and thus may represent different receptor domains.

AB - Neurochemical studies have indicated that the dissociative anesthetics, phencyclidine (PCP) and ketamine, act as non-competitive antagonists at the excitatory amino acid, N-methyl-d-aspartate (NMDA), receptor-gated ion channel. Since the binding of PCP and related psychotomimetics, i.e. (+)-N-allylnormetazocine ((+)-SKF 10047), in mammalian brain is associated with multiple receptor subtypes, their modulation by NMDA agonists and antagonists was investigated. Binding of the potent PCP analog, [3H]PCP-3-OH to the high-affinity sigma/PCP (σp) site and (+)-[3H]SKF 10047 to the sigma/haloperidol sensitive (σh) site in rat brain membranes was not affected by l-glutamate and NMDA, nor by the competitive NMDA antagonists d-2-amino-5-phosphovaleric acid (AP-5), d-2-amino-7-phosphoheptanoic acid (AP-7). However, binding of [3H]PCP-3-OH to the low-affinity PCP-selective site was enhanced by 4- to 5-fold in the presence of glutamate or NMDA and reduced in a competitive manner by AP-5. The non-competitive NMDA antagonist, MK-801, was however a potent inhibitor of the binding to both σp and PCP sites labeled with [3H]PCP-3-OH. The present results indicate that the high (σp) and low-affinity (PCP) sites, that are distinct from the σh site, are affected differently by NMDA agonists and antagonists, and thus may represent different receptor domains.

KW - (+)-N-Allylnormetazocine

KW - Excitatory amino acid

KW - N-Methyl-d-aspartate

KW - Phencyclidine

KW - Receptor regulation

KW - Receptor subtype

UR - http://www.scopus.com/inward/record.url?scp=0024436397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024436397&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(89)90595-8

DO - 10.1016/0304-3940(89)90595-8

M3 - Article

C2 - 2573019

AN - SCOPUS:0024436397

VL - 104

SP - 314

EP - 319

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -